Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318707 · ClinicalTrials.gov registry record
Biomarkers Serum Collection Methodology Pilot Study
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 20
- Enrollment target
NCT01318707: Completed study, sponsored by Georgetown University.
NCT01318707 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318707 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-05 |
What the finished NCT01318707 record still lists
NCT01318707 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01318707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01318707 about?
NCT01318707 is a clinical study titled "Biomarkers Serum Collection Methodology Pilot Study". The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.
What is the current status of trial NCT01318707?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01318707?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia